Myriad Genetics, Inc. · Salt Lake City, UT United States (NASDAQ: MYGN)
| 320 Wakara Way | Phone: 801-584-3600 |
| Salt Lake City, UT | Fax: 801-584-3640 |
| 84108 | |
| United States | 
Map This Company |
Myriad Genetics, Inc. Rankings
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
There are a myriad of diseases out there, and Myriad Genetics is working to detect which ones you might develop based on your genes. The company develops and sells molecular diagnostic tests in three main areas: predictive medicine (to assess a patient's risk for developing disease), personalized medicine (to identify likelihood of drug response to therapies), and prognostic medicine (to assess risk of disease progression or recurrence). Its biggest revenue maker, BRACAnalysis, helps determine risk for breast or ovarian cancer. Myriad Genetics markets its products in the US through its own sales force and uses collaborations to sell them elsewhere. It spun off its drug development operations in mid-2009.
Myriad Genetics, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: MYGN Headquarters |
|---|---|
| Fiscal Year-End | June |
| 2011 Employees | 1,057 |
Executives
67 executives listed for Myriad Genetics, Inc.'s Salt Lake City, UT location.
| Chairman | John Henderson | |
|---|---|---|
| Vice Chairman | Walter Gilbert | |
| President, CEO, and Director | Peter Meldrum |